This study explores the correlation between stool characteristics measured by AI and physicians with inflammation in patients hospitalized with acute severe ulcerative colitis (ASUC). Using AI and manual scoring, the study found that certain stool characteristics, like the Bristol stool scale and stool consistency, significantly correlated with C-reactive protein (CRP) levels, a marker of inflammation. The findings suggest that smartphone-based AI tools could serve as noninvasive methods for monitoring UC disease activity in clinical settings, potentially improving patient care through more precise monitoring.
Trending
- 5 doctors weigh in on the promise, limitations of Grail’s multicancer test (Medtech Dive)
- IBS Pain Closely Linked to Interrelated Daily-Life Triggers (Physicians Weekly)
- First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication (Takeda)
- Industry Voices—How physician practices can grow and succeed without the support of private equity (Fierce Healthcare)
- Blood-Based CRC Test Upgrades Improve on Precancerous Lesion Detection (Medscape)
- Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing (Lucid Diagnostics)
- How Can GI Fellowship Programs Enhance Ambulatory Training? (Yale School of Medicine)
- VIOVOC Issued U.S. Patent for Ambient Sensing Technology That Decodes Gut Microbiome Signals (Business Wire)
